A paper published on April 5th in the New England Journal of Medicine entitled “Protection by a Fourth Dose of BNT162b2 against Omicron in Israel” is raising eyebrows in the scientific world because of its deficiencies. By Guy HatchardDr. Vinay Prasad is an American hematologist–oncologist and health researcher. He is an associate professor of Epidemiology and Biostatistics at the University of California, San Francisco. His work has coined the term medical reversal whereby more careful trials of a drug show that its earlier approval was flawed.Dr Prasad, who is not an anti vaxxer by any stretch of the imagination,...